progyny is the leading fertility benefits company that combines service, science, technology and data to provide fertility solutions for self-insured employers. progyny’s approach offers members a comprehensive value based treatment plan that is based on the latest medical science and technology. the benefit plans are designed to improve outcomes, shorten time to pregnancy and reduce total fertility-related costs. progyny supports all fertility solutions to include ivf, iui, embryo banking, egg freezing, adoption and surrogacy.
Company profile
Ticker
PGNY
Exchange
Website
CEO
David J. Schlanger
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Auxogyn Inc, Auxogyn, Inc.
SEC CIK
Corporate docs
IRS number
272220139
PGNY stock data
Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
12 Apr 24
DEFA14A
Additional proxy soliciting materials
12 Apr 24
DEF 14A
Definitive proxy
12 Apr 24
S-8
Registration of securities for employees
29 Feb 24
10-K
2023 FY
Annual report
29 Feb 24
8-K
Progyny, Inc. Announces Fourth Quarter 2023 Results
27 Feb 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
8-K
Progyny, Inc. Announces Third Quarter 2023 Results
7 Nov 23
10-Q
2023 Q2
Quarterly report
4 Aug 23
8-K
Progyny, Inc. Announces Second Quarter 2023 Results
3 Aug 23
Transcripts
PGNY
Earnings call transcript
2023 Q4
27 Feb 24
PGNY
Earnings call transcript
2023 Q3
7 Nov 23
PGNY
Earnings call transcript
2023 Q2
3 Aug 23
PGNY
Earnings call transcript
2023 Q1
8 May 23
PGNY
Earnings call transcript
2022 Q4
27 Feb 23
PGNY
Earnings call transcript
2022 Q3
4 Nov 22
PGNY
Earnings call transcript
2022 Q2
7 Aug 22
PGNY
Earnings call transcript
2022 Q1
6 May 22
PGNY
Earnings call transcript
2021 Q4
1 Mar 22
PGNY
Earnings call transcript
2021 Q3
5 Nov 21
Latest ownership filings
4
Peter Anevski
3 Apr 24
4
David J Schlanger
3 Apr 24
4
Michael E Sturmer
3 Apr 24
4
Mark S. Livingston
3 Apr 24
4
Allison Swartz
3 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
4
David J Schlanger
29 Mar 24
4
David J Schlanger
27 Mar 24
4
David J Schlanger
25 Mar 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 158.08 mm | 158.08 mm | 158.08 mm | 158.08 mm | 158.08 mm | 158.08 mm |
Cash burn (monthly) | 4.17 mm | (no burn) | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 28.55 mm | n/a | n/a | n/a | n/a | n/a |
Cash remaining | 129.53 mm | n/a | n/a | n/a | n/a | n/a |
Runway (months of cash) | 31.1 | n/a | n/a | n/a | n/a | n/a |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 320 |
Opened positions | 47 |
Closed positions | 34 |
Increased positions | 142 |
Reduced positions | 85 |
13F shares | Current |
---|---|
Total value | 3.13 tn |
Total shares | 105.50 mm |
Total puts | 274.70 k |
Total calls | 635.60 k |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 11.00 mm | $374.15 bn |
Vanguard | 8.16 mm | $277.52 bn |
TPG GP A | 6.60 mm | $224.45 bn |
Kleiner Perkins Caufield & Byers Xiii | 6.47 mm | $325.94 mm |
KPCB XIII Associates | 5.07 mm | $172.64 bn |
MKGAF Merck KGaA | 4.30 mm | $182.17 mm |
Clearbridge Advisors | 3.94 mm | $134.06 bn |
Fred Alger Management | 3.21 mm | $109.30 bn |
Jennison Associates | 2.71 mm | $92.07 bn |
STT State Street | 2.68 mm | $91.15 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Apr 24 | Schlanger David J | Common Stock | Sell | Dispose S | No | Yes | 37.5225 | 1,000 | 37.52 k | 83,631 |
1 Apr 24 | Schlanger David J | Common Stock | Payment of exercise | Dispose F | No | No | 38.15 | 2,681 | 102.28 k | 84,631 |
1 Apr 24 | Schlanger David J | Common Stock | Option exercise | Acquire M | No | No | 3.95 | 1,000 | 3.95 k | 87,312 |
1 Apr 24 | Schlanger David J | Stock Option Common Stock | Option exercise | Dispose M | No | No | 3.95 | 1,000 | 3.95 k | 1,309,022 |
1 Apr 24 | Anevski Peter | Common Stock | Payment of exercise | Dispose F | No | No | 38.15 | 7,977 | 304.32 k | 247,917 |
27 Mar 24 | Schlanger David J | Common Stock | Sell | Dispose S | No | Yes | 37.8026 | 71,272 | 2.69 mm | 86,312 |
27 Mar 24 | Schlanger David J | Common Stock | Option exercise | Acquire M | No | No | 3.9545 | 71,272 | 281.85 k | 157,584 |
27 Mar 24 | Schlanger David J | Stock Option Common Stock | Option exercise | Dispose M | No | No | 3.9545 | 71,272 | 281.85 k | 1,310,022 |
26 Mar 24 | Schlanger David J | Common Stock | Sell | Dispose S | No | Yes | 37.5034 | 305 | 11.44 k | 86,312 |
26 Mar 24 | Schlanger David J | Common Stock | Option exercise | Acquire M | No | No | 3.9545 | 305 | 1.21 k | 86,617 |
News
Truist Securities Reiterates Buy on Progyny, Maintains $46 Price Target
17 Apr 24
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
28 Feb 24
Cantor Fitzgerald Reiterates Overweight on Progyny, Maintains $48 Price Target
28 Feb 24
Truist Securities Maintains Buy on Progyny, Lowers Price Target to $46
28 Feb 24
Keybanc Maintains Overweight on Progyny, Lowers Price Target to $43
28 Feb 24
Press releases
Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care
17 Apr 24
Progyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast
4 Apr 24
Progyny, Inc. to Present at Barclays 26th Annual Global Healthcare Conference
11 Mar 24
Progyny, Inc. Announces Share Repurchase Program
29 Feb 24
Progyny, Inc. Announces Fourth Quarter 2023 Results
27 Feb 24